Back to mobile site

More on KYMR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)
- Holders

Upcoming Events

- Earnings (7/31/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Kymera Therapeutics (NQ:KYMR)
Delayed: 119.00 +4.84 (4.24%)
Prev. Close $114.16  
Open$114.15 
52 Wk High$ 
52 Wk Low$ 
Day High$119.08 
Day Low$113.35 
P/E N/A  
EPS$ 
Volume580,196 

Friends, Peers and Foes (?): ASND, BIIB, DYN, GILD, XENE (more...)

Jul 7, 2026 08:01 PM Form 4 Kymera Therapeutics, For: Jul 07 Filed by: Mainolfi Nello
Jul 7, 2026 04:07 PM Form 144 Kymera Therapeutics, Filed by: Mainolfi Nello
Jul 7, 2026 07:00 AM Kymera Therapeutics names ex-Sanofi executive to lead KT-621 program
Jul 7, 2026 07:00 AM Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
Jul 2, 2026 06:30 PM Form 4 Kymera Therapeutics, For: Jul 01 Filed by: Goodman Noah
Jul 2, 2026 06:30 PM Form 4 Kymera Therapeutics, For: Jun 30 Filed by: Jacobs Bruce N.
Jul 2, 2026 06:30 PM Form 4 Kymera Therapeutics, For: Jul 01 Filed by: Mainolfi Nello
Jul 2, 2026 05:39 PM Form 4/A Kymera Therapeutics, For: Jun 26 Filed by: Booth Bruce
Jul 2, 2026 08:33 AM Form 144 Kymera Therapeutics, Filed by: Mainolfi Nello
Jul 1, 2026 04:58 PM Form 144 Kymera Therapeutics, Filed by: Goodman Noah
View All Articles

Entities mentioned with KYMR

View All Entities